At a Senate hearing, Kennedy also said the president has directed him to examine the well-established safety of mifepristone, ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio raised $600 million combined and Allakos laid off staff.

Federal agencies must stop disbursing financial assistance under a new budget directive, threatening funding for providers ...

The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...